231 related articles for article (PubMed ID: 28597812)
1. Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of Nutritional Disorders?
Plovier H; Cani PD
Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28597812
[TBL] [Abstract][Full Text] [Related]
2. Interplay of Gut Microbiota, Probiotics in Obesity: A Review.
Pothuraju R; Sharma RK
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):212-220. PubMed ID: 29384067
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
Frazier TH; DiBaise JK; McClain CJ
JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and energy balance: role in obesity.
Blaut M
Proc Nutr Soc; 2015 Aug; 74(3):227-34. PubMed ID: 25518735
[TBL] [Abstract][Full Text] [Related]
5. The gut microbiome as therapeutic target.
Cani PD; Delzenne NM
Pharmacol Ther; 2011 May; 130(2):202-12. PubMed ID: 21295072
[TBL] [Abstract][Full Text] [Related]
6. Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity.
Cândido FG; Valente FX; Grześkowiak ŁM; Moreira APB; Rocha DMUP; Alfenas RCG
Int J Food Sci Nutr; 2018 Mar; 69(2):125-143. PubMed ID: 28675945
[TBL] [Abstract][Full Text] [Related]
7. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota: a potential manipulator for host adipose tissue and energy metabolism.
Bohan R; Tianyu X; Tiantian Z; Ruonan F; Hongtao H; Qiong W; Chao S
J Nutr Biochem; 2019 Feb; 64():206-217. PubMed ID: 30553096
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
10. Intestinal microbiota and obesity.
Blaut M; Klaus S
Handb Exp Pharmacol; 2012; (209):251-73. PubMed ID: 22249818
[TBL] [Abstract][Full Text] [Related]
11. Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota.
Alard J; Lehrter V; Rhimi M; Mangin I; Peucelle V; Abraham AL; Mariadassou M; Maguin E; Waligora-Dupriet AJ; Pot B; Wolowczuk I; Grangette C
Environ Microbiol; 2016 May; 18(5):1484-97. PubMed ID: 26689997
[TBL] [Abstract][Full Text] [Related]
12. Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications.
Molinaro F; Paschetta E; Cassader M; Gambino R; Musso G
Gastroenterol Clin North Am; 2012 Dec; 41(4):843-54. PubMed ID: 23101690
[TBL] [Abstract][Full Text] [Related]
13. Connection between gut microbiome and the development of obesity.
Zhi C; Huang J; Wang J; Cao H; Bai Y; Guo J; Su Z
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):1987-1998. PubMed ID: 31367997
[TBL] [Abstract][Full Text] [Related]
14. Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pyroptosis during obesity.
Hersoug LG; Møller P; Loft S
Nutr Res Rev; 2018 Dec; 31(2):153-163. PubMed ID: 29362018
[TBL] [Abstract][Full Text] [Related]
15. Implication of the Gut Microbiota in Metabolic Inflammation Associated with Nutritional Disorders and Obesity.
Rodriguez J; Olivares M; Delzenne NM
Mol Nutr Food Res; 2021 Jan; 65(1):e1900481. PubMed ID: 33111450
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
[TBL] [Abstract][Full Text] [Related]
17. The gut microbiota, obesity and insulin resistance.
Shen J; Obin MS; Zhao L
Mol Aspects Med; 2013 Feb; 34(1):39-58. PubMed ID: 23159341
[TBL] [Abstract][Full Text] [Related]
18. Dysbiosis and metabolic endotoxemia induced by high-fat diet.
Netto Candido TL; Bressan J; Alfenas RCG
Nutr Hosp; 2018 Dec; 35(6):1432-1440. PubMed ID: 30525859
[TBL] [Abstract][Full Text] [Related]
19. Bifidobacterium adolescentis IM38 ameliorates high-fat diet-induced colitis in mice by inhibiting NF-κB activation and lipopolysaccharide production by gut microbiota.
Lim SM; Kim DH
Nutr Res; 2017 May; 41():86-96. PubMed ID: 28479226
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota and metabolic syndrome.
Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
